semaglutide gallbladder lawsuit Ozempic Ongoing Developments [2026 Updates] Weight Loss Drug Lawsuit Attorneys

These are recognised class effects associated with GLP-1based therapies

Jump straight to the products built for your goal each one hand-picked to work together

For the vast majority of healthy researchers, this heart rate increase is clinically insignificant

Zepbound (tirzepatide) uses Eli Lilly's KwikPen auto-injector with 4 doses per pen, once-weekly subcutaneous injection

06/26/25 CAR T cell immunotherapies Updated labeling and elimination of REMS June 26, 2025 - The FDA approved updated labeling for currently approved BCMA- and CD19-directed autologous chimeric antigen receptor (CAR) T cell immunotherapies and eliminated the Risk Evaluation and Mitigation Strategies (REMS) program for these products